Todays Report: Today, Nutrisystem Inc. (NTRI) Insider Sold $895,250.00 in Stock

Today, Nutrisystem Inc. (NTRI) Insider Sold $895,250.00 in Stock

Nutrisystem Inc. (NASDAQ:NTRI) insider Dawn M. Zier sold 25,000 shares of the business’s stock in a transaction that occurred on Monday, November 21st. The shares were sold at an average price of $35.81, for a total transaction of $895,250.00. Following the completion of the sale, the insider now directly owns 247,171 shares in the company, valued at $8,851,193.51. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Nutrisystem Inc. (NASDAQ:NTRI) opened at 37.30 on Friday. The firm’s 50-day moving average is $32.56 and its 200 day moving average is $28.68. Nutrisystem Inc. has a 12-month low of $17.25 and a 12-month high of $37.45. The firm has a market cap of $1.10 billion, a PE ratio of 36.18 and a beta of 0.87.

Nutrisystem (NASDAQ:NTRI) last released its quarterly earnings results on Wednesday, October 26th. The company reported $0.27 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.26 by $0.01. Nutrisystem had a net margin of 5.78% and a return on equity of 43.89%. The company had revenue of $124.60 million for the quarter, compared to analysts’ expectations of $238.36 million. During the same period last year, the company earned $0.25 EPS. The firm’s revenue for the quarter was up 18.8% compared to the same quarter last year. Equities research analysts predict that Nutrisystem Inc. will post $1.13 EPS for the current year.

The company also recently declared a quarterly dividend, which was paid on Thursday, November 17th. Shareholders of record on Monday, November 7th were paid a dividend of $0.175 per share. The ex-dividend date was Thursday, November 3rd. This represents a $0.70 annualized dividend and a dividend yield of 1.88%. Nutrisystem’s dividend payout ratio is currently 67.96%.

Several large investors have recently added to or reduced their stakes in the company. Emerald Advisers Inc. PA boosted its stake in Nutrisystem by 150.8% in the second quarter. Emerald Advisers Inc. PA now owns 942,255 shares of the company’s stock valued at $23,896,000 after buying an additional 566,608 shares in the last quarter. Emerald Mutual Fund Advisers Trust bought a new stake in Nutrisystem during the second quarter valued at about $12,916,000. Rice Hall James & Associates LLC bought a new stake in Nutrisystem during the second quarter valued at about $1,636,000. Swiss National Bank boosted its stake in Nutrisystem by 3.0% in the second quarter. Swiss National Bank now owns 48,800 shares of the company’s stock valued at $1,238,000 after buying an additional 1,400 shares in the last quarter. Finally, BlackRock Group LTD boosted its stake in Nutrisystem by 8.2% in the first quarter. BlackRock Group LTD now owns 40,297 shares of the company’s stock valued at $840,000 after buying an additional 3,042 shares in the last quarter. 95.76% of the stock is currently owned by institutional investors.

A number of equities research analysts have recently issued reports on the stock. B. Riley reissued a “buy” rating and issued a $41.00 price target on shares of Nutrisystem in a research note on Monday, October 24th. Barrington Research upped their target price on shares of Nutrisystem from $35.00 to $37.00 and gave the stock an “outperform” rating in a research note on Monday, October 31st. Wunderlich upped their target price on shares of Nutrisystem from $31.00 to $37.00 and gave the stock a “buy” rating in a research note on Wednesday, October 19th. Argus assumed coverage on shares of Nutrisystem in a research note on Friday, November 11th. They set a “buy” rating and a $40.00 target price on the stock. Finally, Zacks Investment Research raised shares of Nutrisystem from a “hold” rating to a “buy” rating and set a $33.00 target price on the stock in a research note on Saturday, July 30th. One analyst has rated the stock with a hold rating and six have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average target price of $36.14.

Nutrisystem Company Profile

Related posts

Leave a Comment